pharmanewsdaily
1509 posts
Teva launches generic version of Delzicol delayed-release capsules in US
Israeli pharma company Teva Pharmaceuticals has launched a generic version of Delzicol (mesalamine) 400mg delayed-release capsules in the…
May 19, 2019
Pharma giants bag Lynparza EMA approval for metastatic breast cancer
Lynparza EMA approval : Pharma giants AstraZeneca and MSD have secured an expansion of the European Medical Agency’s…
May 19, 2019
Vaxiion begins VAX014 phase 1 trial in non-muscle invasive bladder cancer
Vaxiion Therapeutics, a clinical stage biotech company based in California, has initiated a phase 1 clinical trial of…
May 18, 2019
ReGenTree begins ARISE-3 trial of RGN-259 eye drops for dry eye syndrome
ReGenTree has initiated a phase 3 clinical trial, called ARISE-3, to evaluate the safety and efficacy of 0.1%…
May 13, 2019
SHINE breaks ground on medical isotope production facility in Janesville, WI
SHINE Medical Technologies, a US radioisotopes manufacturer, began construction on its first medical isotope production facility in Janesville…
May 10, 2019
Genentech gets Kadcyla FDA approval for post-surgery treatment of HER2+ EBC
Kadcyla FDA approval : Roche subsidiary Genentech has secured approval from the US Food and Drug Administration (FDA)…
May 5, 2019
Imbed Biosciences secures financing for MicroLyte Ag Antimicrobial Matrix
Imbed Biosciences, a Wisconsin-based medical device company, development of advanced therapies for soft tissue repair, has raised $2…
April 27, 2019
Wayne Pharmaceuticals launches Dr Wayne’s Aspirin in US
Wayne Pharmaceuticals has launched Dr Wayne’s Aspirin Tablets in the US in a bottle package containing 300 tablets,…
April 27, 2019
How to get rid of hiccups? Common tried and tested ways to treat hiccups
Almost everyone gets hiccups that are annoying at times. Usually it goes off after few minutes but it…
April 26, 2019
Dr Reddy’s Laboratories to acquire generic injectable products in the US
Dr Reddy’s Laboratories has agreed to acquire a portfolio of 42 approved, non-marketed abbreviated new drug applications (ANDAs)…
April 19, 2019